← Back to Conditions

Pterygium

disorder
SNOMED 77489003CUI C4520843

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Clinical Trials

9
Total Trials
0
Recruiting
1
With Results

Recent Trials

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

NCT03521791Phase 4Completed166 enrolled

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

NCT04075227Phase 4Completed108 enrolled

Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients

NCT05314673Phase 4Completed60 enrolled

Effect of Bromfenac on Pain Related to Pterygium Surgery

NCT04022811Phase 4Completed60 enrolled

The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision

NCT05978687Phase 4Completed41 enrolled
View all 9 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abnormal conjunctiva morphology
HP:0000502
Pterygia
HP:0001059

Related Conditions

Double pterygium(child)
Central pterygium(child)
Recurrent pterygium(child)
Peripheral pterygium(child)
Autosomal dominant pterygium of conjunctiva(child)
Pterygium of right eye(child)
Pterygium of left eye(child)
Conjunctival degeneration(parent)
Corneal lesion(parent)

Quick Facts

SNOMED CT
77489003
UMLS CUI
C4520843
Fully Specified Name
Pterygium (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
2
Clinical Trials
9
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.